Literature DB >> 9880547

Mitogen-activated protein kinase is involved in the degradation of p53 protein in the bryostatin-1-induced differentiation of the acute promyelocytic leukemia NB4 cell line.

X Song1, H M Sheppard, A W Norman, X Liu.   

Abstract

Overexpression of mutant p53 has been reported to promote tumorigenicity in several cancers. However, despite its potential importance, the signals regulating mutant p53 protein expression are not known. Here we show that a form of p53 that is incapable of binding DNA is overexpressed in the acute promyelocytic leukemia NB4 cell line. Our results demonstrate that treatment of NB4 cells with bryostatin-1, which induces differentiation in this cell line, leads to hyperphosphorylation of this DNA binding-impaired form of p53 via mitogen-activated protein kinase. After this phosphorylation, the p53 protein is degraded by the ubiquitin/proteasome pathway. Furthermore, we show that inhibition of p53 hyperphosphorylation blocks p53 protein degradation and cell differentiation. In addition, inhibition of the ubiquitin/proteasome pathway also blocks p53 protein degradation and cell differentiation. These findings suggest a role for mitogen-activated protein kinase in the degradation of the DNA binding-impaired form of p53 protein and in the bryostatin-induced differentiation observed in this cell line. The implications of these results with respect to the functional significance of p53 phosphorylation and degradation in cell differentiation are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880547     DOI: 10.1074/jbc.274.3.1677

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Overlapping and divergent actions of estrogen and the neurotrophins on cell fate and p53-dependent signal transduction in conditionally immortalized cerebral cortical neuroblasts.

Authors:  S B Wade; P Oommen; W C Conner; D J Earnest; R C Miranda
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

2.  Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.

Authors:  Majid Momeny; Majid Zakidizaji; Reza Ghasemi; Ahmad R Dehpour; Maryam Rahimi-Balaei; Yassan Abdolazimi; Ardeshir Ghavamzadeh; Kamran Alimoghaddam; Seyed H Ghaffari
Journal:  Med Oncol       Date:  2009-09-10       Impact factor: 3.064

3.  HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia.

Authors:  Aida Vitkevičienė; Giedrė Skiauterytė; Andrius Žučenka; Mindaugas Stoškus; Eglė Gineikienė; Veronika Borutinskaitė; Laimonas Griškevičius; Rūta Navakauskienė
Journal:  J Oncol       Date:  2019-07-18       Impact factor: 4.375

4.  Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.

Authors:  Line Wergeland; Gry Sjøholt; Ingvild Haaland; Randi Hovland; Øystein Bruserud; Bjørn Tore Gjertsen
Journal:  Mol Cancer       Date:  2007-05-11       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.